534 Followers on Owler

Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases...

Read more

Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases...

Read more
Theravance Biopharma Chairman & CEO: Rick E. Winningham

Chairman & CEO

Rick E. Winningham

CEO Approval Rating

90/100

Annual Revenue
$51.3M
Employees
110
Funding
803.4M

Theravance Biopharma Competitors

1
2
3
4
5
6
7
8
9
10
See 12+ competitors

Theravance Biopharma Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$51.3M

Theravance Biopharma's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 1.3B. Over the last four quarters, Theravance Biopharma's revenue has grown by 11%. Specifically, in Q4 2022's revenue was $14.6M; in Q3 2022, it was $12.5M; in Q2 2022, it was $11.1M; in Q1 2022, Theravance Biopharma's revenue was $13.2M.

Theravance Biopharma News

Theravance Biopharma Press Releases

Theravance Biopharma Headquarters

901 Gateway Boulevard

South San Francisco, California94080

1-650-808-6000

Driving Directions »

Theravance Biopharma Summary

ABOUT

Overview

Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases. Theravance Biopharma was founded in 1996. Theravance Biopharma's headquarters is located in South San Francisco, Cal...

CEO

Theravance Biopharma's Chairman & CEO, Rick E. Winningham, currently has an approval rating of 90%. Theravance Biopharma's primary competitors are AcelRx, Pulmatrix, Altavant Sciences and 9 more.

Acquisitions

There have been no acquisitions found related to Theravance Biopharma

Investments

Recent investment data cannot be found related to Theravance Biopharma

Frequently Asked Questions about Theravance Biopharma

  1. When was Theravance Biopharma founded?

    Theravance Biopharma was founded in 1996
  2. Who is Theravance Biopharma's CEO?

    Theravance Biopharma's CEO is Rick E. Winningham
  3. How much revenue does Theravance Biopharma generate?

    Theravance Biopharma generates $51.3M in revenue
  4. How much funding does Theravance Biopharma have?

    Theravance Biopharma has historically raised $803.4M in funding
  1. Where is Theravance Biopharma's headquarters?

    Theravance Biopharma's headquarters is in South San Francisco California, USA
  2. How many employees does Theravance Biopharma have?

    Theravance Biopharma has 110 employees
  3. What sector does Theravance Biopharma operate in?

    Theravance Biopharma is in Pharmaceuticals, Biotechnology
  4. Who are Theravance Biopharma's competitors?

    Theravance Biopharma's top competitors are AcelRx, Pulmatrix, Altavant Sciences

Trending Companies